• Home
  • Team
  • Services
  • Portfolio
    • Cleantech
      • Consulting Energy Control
      • Lumartix
      • PVSyst
    • Healthcare
      • Anteis
      • Augurix
      • BioXpress Therapeutics
      • Leman Medical Technologies
      • Medicontur
      • Powersens
      • Viroblock
    • ICT
      • Abilis
      • inZair
      • Tegona
    • IT
      • salsaDev
    • Life Sciences
      • Selexis
    • Nanotechnology
      • Dextens
      • Manep
      • Phasis
  • Partners
    • VentureLab
    • Venture Kick
    • CTI
    • CTI Startup
    • CTI Invest
    • AlpICT
    • CleantechAlps
    • Eclosion
    • Economic Development Service
    • OPI
    • HUG
    • UNITEC
    • MedC Partners
    • BlueOcean Ventures
    • Business Angels Switzerland
    • Startup Weekend
  • FAQ
  • News
  • Investors
  • Accelerators
  • Workshops
  • Jobs Board
  • Apply
  • Contact

FONGIT

The Start up Factory

Powersens

January 20, 2012 by admin

Powersens is a start up developing and selling smart electronic shoe-insoles for the medical market. The insoles placed inside the shoe, monitors and records foot plantar pressure and body movement throughout the day.

 

They help users for interactive walking/sport rehabilitation and can diagnostic orthopaedic complications such as diabetic foot ulcers. This high potential medical device will improve lifetime and health conditions of millions of people.

Filed Under: Diagnostic, Featured, Fongit, Foot, Healthcare, MedTech, Orthopaedic, Plantar pressure, Sensors, Shoe-insole, Sport

BioXpress Therapeutics

November 15, 2011 by admin

Located in Geneva, Switzerland, BioXpress Therapeutics SA (BXT) is a premier provider of high-quality biosimilar monoclonal antibody (MAbs) for unmet need indications. As a class, MAbs are forecasted to grow at a CAGR approaching 10% over the next five years, driven largely by positive results in the clinic. Cancers and immune-related inflammatory diseases will continue to be leading markets for MAbs during the next five-years.

BXT is focused on developing the highest quality product under strict European Medicines Agency (EMA) guidelines. We bring together the world’s top biologic development, manufacturing and regulatory experts dedicated to assuring the quality of our drugs. BXT believes all patients should have access to safe and high-quality biologic therapeutics at affordable costs.

Filed Under: Biosimilar, Featured, Fongit, Fongit Seed Invest, Healthcare

MedC Partners

November 10, 2011 by admin

MedC Partners is a service and consulting firm dedicated to develop market access strategies for medical device companies in Switzerland and Europe. It assists its clients – start-ups, mid-size companies and corporations – on regulatory affairs, and reimbursement and marketing issues. It is also engaged in due diligence on behalf of investors and financial groups.

MedC Partners has developed an exclusive and novel approach enabling its customers to: take into account all the key factors from the first stages of product development, (ii) accelerate access to the European market, (iii) determine the most suitable markets and identify distributors, and (iv) generate faster and better financial returns.

Filed Under: Consulting, Fongit, Healthcare, MedTech

Augurix

May 10, 2011 by admin

Augurix product allows the screening, diagnosing and monitoring of Celiac Disease (intolerance to gluten), one of the most under-diagnosed medical conditions worldwide.

Its proprietary diagnostic platform, Simtomax®Blood Drop, enables seamless and rapid screening at the point of care, from whole blood, serum, plasma in about 10 minutes. Using a small drop of blood, Simtomax® Blood Drop delivers lab-accurate results for: (i) Immunoglobulin-A (IgA), (ii) Immunoglobulin-G (IgG) and (iii) Total IgA level. Simtomax, CE compliant Augurix’ first product-line received the 2010 Frost&Sullivan Product Differentiation Excellence Award in Point of Care Testing.

Augurix is a family-driven business. Its family’s personal experience of living with Celiac Disease is a constant reminder that drives its motivation.

Filed Under: Featured, Fongit, Healthcare

Viroblock

May 3, 2011 by admin

Viroblock aims to launch a break through anti-viral face mask by mid 2012. Current face-masks (surgical, FFP2, N95) provide limited protection to wearers against respiratory viruses (H1N1,H5N1, SARS, RSV, etc) as they fail to filter out or kill these viruses. The new Viroblock mask uses a patented coating to kill all such viruses on pass through air thereby protecting the wearer and reducing infection.

Targeted first at professionals who have a risk of viral infections (e.g., dentists, A&E staff, first responders). Viroblock technology has been shown to kill all enveloped viruses tested, including H1N1, H5N1, SARS, HIV and HSV. No resistance has been seen nor is expected as Viroblock technology targets a non-coded part of these viruses. Viroblock’s technology can be used in other products (e.g. nasal spray, vaginal gel).

Filed Under: Featured, Fongit, Healthcare, Viroblock

VentureKick VentureLab Aesthetic dermatology (1)
AFM (1)
Antibodies (1)
Artery banding (1)
Augurix (1)
Bio-therapeutics (1)
Biopolymers (1)
Biosimilar (2)
BlueOcean Ventures (1)
Cataract (1)
Cell-based assay (1)
Cell-line development (1)
Cleantech (2)
Consulting (2)
Content Analytics (1)
CTI (3)
CTI Start up (2)
Dextens (1)
Diagnostic (1)
Epigenetics (1)
Featured (9)
FloWatch (1)
Fongit (13)
Fongit Seed Invest (5)
Foot (1)
Funding (4)
Gaming (1)
gene expression (1)
Geolocalisation (1)
Hard skills (1)
Healthcare (5)
Injectable (1)
InjectNow (1)
Innovation (3)
Intraocular lens implant (1)
Investment (3)
Legal (1)
MedTech (3)
Messaging (1)
Metallurgy (1)
Micro-credit (1)
Micro-health (1)
Micro-insurance (1)
Microscopy (1)
Microscopy substrate (1)
NFC (1)
Ophthalmology (1)
Orthopaedic (1)
Orthopaedics (1)
PAB (1)
Plantar pressure (1)
Private Equity (1)
Protein expression (1)
Protein production (1)
R&D (1)
Recombinant proteins (1)
Recruiters (1)
SalsaDev (1)
Security (1)
Semantic (1)
Semantic Meaning (1)
Sensors (2)
Shoe-insole (1)
Smartcard (1)
Soft skills (1)
Space-time (1)
Sport (1)
STM (1)
Superconductor (1)
Talent matching (1)
Thin film (2)
Training (1)
Value network (1)
Venture Capital (3)
Viroblock (2)
Wireless (1)
Workshops (2)
ZMS (1)

WP Cumulus Flash tag cloud by Roy Tanck requires Flash Player 9 or better.

Return to top of page

Copyright FONGIT © 2012 · Terms of Use · Log in